Metabolism‐Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy
Small · 2024
DOI: 10.1002/smll.202307794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Chang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Outstanding Youth Fund of Guangdong Province, Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases.
Abstract (Originalsprache)
Nanocatalytic therapy, an emerging approach in cancer treatment, utilizes nanomaterials to initiate enzyme‐mimetic catalytic reactions within tumors, inducing tumor‐suppressive effects. However, the targeted and selective catalysis within tumor cells is challenging yet critical for minimizing the adverse effects. The distinctive reliance of tumor cells on glycolysis generates abundant lactate, influencing the tumor's pH, which can be manipulated to selectively activate nanozymatic catalysis. Herein, small interfering ribonucleic acid (siRNA) targeting lactate transporter‐mediated efflux is encapsulated within the iron‐based metal–organic framework (FeMOF) and specifically delivered to tumor cells through cell membrane coating. This approach traps lactate within the cell, swiftly acidifying the tumor cytoplasm and creating an environment for boosting the catalysis of the FeMOF nanozyme. The nanozyme generates hydroxyl radical (·OH) in the reversed acidic environment, using endogenous hydrogen peroxide (H 2 O 2 ) produced by mitochondria as a substrate. The induced cytoplasmic acidification disrupts calcium homeostasis, leading to mitochondrial calcium overload, resulting in mitochondrial dysfunction and subsequent tumor cell death. Additionally, the tumor microenvironment is also remodeled, inhibiting migration and invasion, thus preventing metastasis. This groundbreaking strategy combines metabolic regulation with nanozyme catalysis in a toxic drug‐free approach for tumor treatment, holding promise for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
- Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
- Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Turku, 20520, Finland.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, 20520, Finland.
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200031, China.
- Industrial Physics Laboratory, Department of Physics and Astronomy, University of Turku, Turku, 20014, Finland.
ORCID-Profile: Chang Liu, Hongbo Zhang
Förderung
- National Natural Science Foundation of China
- Natural Outstanding Youth Fund of Guangdong Province
- Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases
- Affiliated Hospital of Guangdong Medical University Clinical Research Program
- China Postdoctoral Science Foundation
- Finnish Ministry of Education and Culture
- Academy of Finland
Zitieren
APA
Liu, C., Xu, X., Chen, Y., Yin, M., Mäkilä, E., Zhou, W., Su, W., & Zhang, H. (2024). Metabolism‐Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy. Small. https://doi.org/10.1002/smll.202307794
Vancouver
Liu C, Xu X, Chen Y, Yin M, Mäkilä E, Zhou W, et al. Metabolism‐Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy. Small. 2024. doi:10.1002/smll.202307794
BibTeX
@article{Liu2024,
author = {Liu, Chang and Xu, Xiaoyu and Chen, Yongyang and Yin, Miao and Mäkilä, Ermei and Zhou, Wenhui and Su, Wenmei and Zhang, Hongbo},
title = {Metabolism‐Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202307794}
}
EUVIMED